在COVID-19中使用抗病毒药物:专注于儿科心脏病患者
Dalia Safi1, Farah Khouri1, Rana Zareef2
1Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
概括
针对COVID-19 (冠状病毒疾病2019) 的抗病毒治疗显示出相互矛盾的结果,特别是在儿科心脏病患者中. 需要更多的研究来证实它们在这个脆弱群体中的有效性.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 儿科 儿科 儿科
背景情况:
- 由于COVID-19大流行,治疗药物的快速开发成为必要,而抗病毒药物成为关键重点.
- 在COVID-19中抗病毒疗效的证据是相互矛盾的,源于各种研究设计和人群.
- 关于儿童COVID-19患者抗病毒使用的数据有限,通常是从成人研究中推断出来的.
研究的目的:
- 评估理由并总结有关COVID-19抗病毒使用的研究结果.
- 特别讨论在COVID-19的儿科心脏病患者中使用抗病毒药物的应用.
主要方法:
- 这篇叙述性综述分析了现有文献,优先考虑随机对照试验的结果.
- 它综合了不同COVID-19严重程度的抗病毒疗效数据.
- 审查的重点是识别知识上的差距,特别是关于儿科人口的差距.
主要成果:
- 关于各种抗病毒药物对COVID-19的疗效存在相互矛盾的证据.
- 观察性研究构成了大部分证据,对许多药物进行了有限的广泛随机对照试验.
- 在儿童COVID-19病例中,针对抗病毒药物的具体研究显著缺乏.
结论:
- 抗病毒药物在控制COVID-19中的有效性需要进一步澄清,因为数据不一致.
- 在COVID-19的儿科心脏病患者中使用抗病毒药物特别缺乏研究,需要专门调查.
- 额外的随机对照试验至关重要,以建立这个人群的最终治疗指南.
更多相关视频
06:03Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
7.8K
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.6K
相关概念视频
01:28Pneumonia IV: Management
271
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
271
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
1.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
107
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
107
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
100
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
100
01:10Retrovirus Life Cycles
45.4K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.4K
01:23Acute Respiratory Failure-IV
113
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
113